These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 571341)

  • 21. Dopaminergic-cholinergic interactions in naloxone-induced circling in morphine-dependent rats with nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    Eur J Pharmacol; 1976 Jul; 38(1):39-54. PubMed ID: 986306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of ciladopa hydrochloride as a potential anti-Parkinson drug.
    Koller WC; Fields JZ; Gordon JH; Perlow MJ
    Neuropharmacology; 1986 Sep; 25(9):973-9. PubMed ID: 3774130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of apomorphine-induced behaviors by derivatives of 2-amino-1, 2, 3, 4-tetrahydronaphthalene.
    Rusterholz DB; Long JP; Flynn JR; Glyn JR; Barfknecht CF; Lind RW; Johnson AK
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):246-60. PubMed ID: 567044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine receptors mediate drug-induced but not Pavlovian conditioned contralateral rotation in the unilateral 6-OHDA animal model.
    Carey RJ
    Brain Res; 1990 May; 515(1-2):292-8. PubMed ID: 2113414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological profile of N,N dipropyl-8-hydroxy-3-chromanamine, an oxygen isostere of the dopamine agonist N,N dipropyl-5-hydroxy-2-aminotetralin with enhanced presynaptic selectivity.
    Vermue NA; Kaptein B; Tepper PG; de Vries JB; Horn AS
    Arch Int Pharmacodyn Ther; 1988; 293():37-56. PubMed ID: 3421784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological evidence for the subclassification of central dopamine receptors in the rat.
    Gower AJ; Marriott AS
    Br J Pharmacol; 1982 Sep; 77(1):185-93. PubMed ID: 6889902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apomorphine stereotypies and transmitter mechanisms in the striatum. I. Changes in the apomorphine stereotypies caused by drugs acting on the GABA-ergic, dopaminergic and cholinergic transmission.
    Georgiev VP; Markovska VL; Petkova BP
    Acta Physiol Pharmacol Bulg; 1978; 4(3):56-64. PubMed ID: 220843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of potency of metoclopramide's metabolites in various dopaminergic models.
    Stanley M; Wazer D; Virgilio J; Kuhn CM; Benson DI; Meyerson LR
    Pharmacol Biochem Behav; 1983 Feb; 18(2):263-6. PubMed ID: 6682229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine 3',5'-cyclic monophosphate as a possible mediator of rotational behaviour induced by dopaminergic receptor stimulation in rats lesioned unilaterally in the substantia nigra.
    Satoh H; Satoh Y; Notsu Y; Honda F
    Eur J Pharmacol; 1976 Oct; 39(2):365-77. PubMed ID: 185065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Denervation in the dopaminergic mesolimbic system: functional changes followed using (-)N-n-propylnorapomorphine depend on the basal activity levels of rats.
    Costall B; Hui SC; Naylor RJ
    Neuropharmacology; 1980 Nov; 19(11):1039-48. PubMed ID: 7192370
    [No Abstract]   [Full Text] [Related]  

  • 31. Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats.
    Rosengarten H; Friedhoff AJ
    Science; 1979 Mar; 203(4385):1133-5. PubMed ID: 570724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 6-Hydroxydopamine lesions of olfactory tubercles and caudate nuclei: effect on amphetamine-induced stereotyped behavior in rats.
    Asher IM; Aghajanian GK
    Brain Res; 1974 Dec; 82(1):1-12. PubMed ID: 4373138
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of nigral dopaminergic firing by N-n-propyl-norapomorphine: behavioural and biochemical correlates.
    Mereu G; Argiolas A; Melis MR; Gessa GL
    Ann Ist Super Sanita; 1982; 18(1):57-61. PubMed ID: 6892092
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug-induced dopaminergic supersensitivity.
    Moore KE; Thornburg JE
    Adv Neurol; 1975; 9():93-104. PubMed ID: 1146661
    [No Abstract]   [Full Text] [Related]  

  • 35. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    Johnson AM; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of dopaminergic agonists and antagonists on serum prolactin concentrations in the rat.
    Horowski R; Gräf HJ
    Neuroendocrinology; 1976; 22(3):273-86. PubMed ID: 1028957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative microfluorimetry of formaldehyde induced fluorescence of dopamine in the caudate nucleus.
    Einarsson P; Hallman H; Jonsson G
    Med Biol; 1975 Feb; 53(1):15-24. PubMed ID: 238082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emetic activity of N-substituted norapomorphines.
    Atkinson ER; Bullock FJ; Granchelli FE; Archer S; Rosenberg FJ; Teiger DG; Nachod FC
    J Med Chem; 1975 Oct; 18(10):1000-3. PubMed ID: 808605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre- and post-synaptic actions of apomorphine: differentiation by rotatory effects in normal rats.
    Glick SD; Jerussi TP; Cox RD; Fleisher LN
    Arch Int Pharmacodyn Ther; 1977 Feb; 225(2):303-7. PubMed ID: 557962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perinatal dopamine-related drugs demasculinize rats.
    Hull EM; Nishita JK; Bitran D; Dalterio S
    Science; 1984 Jun; 224(4652):1011-3. PubMed ID: 6719125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.